The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Erythropoietin Improved Neurologic Outcomes in Newborns With Hypoxic-Ischemic Encephalopathy
Abstract
OBJECTIVE: The purpose of this study was to evaluate the efficacy and safety of erythropoietin in neonatal hypoxic-ischemic encephalopathy (HIE), by using a randomized, prospective study design. METHODS: A total of 167 term infants with moderate/severe HIE were assigned randomly to receive either erythropoietin (N = 83) or conventional treatment (N = 84). Recombinant human erythropoietin, at either 300 U/kg (N = 52) or 500 U/kg (N = 31), was administered every other day for 2 weeks, starting <48 hours after birth. The primary outcome was death or disability. Neurodevelopmental outcomes were assessed at 18 months of age. RESULTS: Complete outcome data were available for 153 infants. Nine patients dropped out during treatment, and 5 patients were lost to follow-up monitoring. Death or moderate/severe disability occurred for 35 (43.8%) of 80 infants in the control group and 18 (24.6%) of 73 infants in the erythropoietin group (P = .017) at 18 months. The primary outcomes were not different between the 2 erythropoietin doses. Subgroup analyses indicated that erythropoietin improved long-term outcomes only for infants with moderate HIE (P = .001) and not those with severe HIE (P = .227). No negative hematopoietic side effects were observed. CONCLUSION: Repeated, low-dose, recombinant human erythropoietin treatment reduced the risk of disability for infants with moderate HIE, without apparent side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palisano, R., Rosenbaum, P., Walter, S., Russell, D., Wood, E., & Galuppi, B. (1997) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1997.tb07414.x · Cited by 6,721
Bayley Scales of Infant Development
(2007) · Encyclopedia of Measurement and Statistics · doi:10.4135/9781412952644.n48 · Cited by 4,240
Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy
Shankaran, S., Laptook, A. R., Ehrenkranz, R. A., Tyson, J. E., McDonald, S. A., Donovan, E. F., Fanaroff, A. A., Poole, W. K., Wright, L. L., Higgins, R. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmcps050929 · Cited by 2,862
Neonatal Encephalopathy Following Fetal Distress: A Clinical and Electroencephalographic Study
Sarnat, H. B. (1976) · Archives of Neurology · doi:10.1001/archneur.1976.00500100030012 · Cited by 2,680
Gluckman, P. D., Wyatt, J. S., Azzopardi, D., Ballard, R., Edwards, A. D., Ferriero, D. M., Polin, R. A., Robertson, C. M., Thoresen, M., Whitelaw, A., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17946-x · Cited by 2,270
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402
Ferriero, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041996 · Cited by 1,142
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
Ehrenreich, H., Hasselblatt, M., Dembowski, C., Cepek, L., Lewczuk, P., Stiefel, M., Rustenbeck, H.-H., Breiter, N., Jacob, S., Knerlich, F., et al. (2002) · Molecular Medicine · doi:10.1007/bf03402029 · Cited by 1,028
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
Sirén, A.-L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051606598 · Cited by 1,019
Moderate hypothermia in neonatal encephalopathy: Efficacy outcomes
Eicher, D. J., Wagner, C. L., Katikaneni, L. P., Hulsey, T. C., Bass, W. T., Kaufman, D. A., Horgan, M. J., Languani, S., Bhatia, J. J., Givelichian, L. M., et al. (2005) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2004.06.014 · Cited by 581
Villa, P., Bigini, P., Mennini, T., Agnello, D., Laragione, T., Cagnotto, A., Viviani, B., Marinovich, M., Cerami, A., Coleman, T. R., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021067 · Cited by 527
THE INFLUENCE OF THE THERMAL ENVIRONMENT UPON THE SURVIVAL OF NEWLY BORN PREMATURE INFANTS
Silverman, W. A., Fertig, J. W., & Berger, A. P. (1958) · Pediatrics · doi:10.1542/peds.22.5.876 · Cited by 518
Thompson, C., Puterman, A., Linley, L., Hann, F., van der Elst, C., Molteno, C., & Malan, A. (1997) · Acta Paediatrica · doi:10.1111/j.1651-2227.1997.tb08581.x · Cited by 466
The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia–ischemia
Zhu, C., Wang, X., Xu, F., Bahr, B. A., Shibata, M., Uchiyama, Y., Hagberg, H., & Blomgren, K. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401545 · Cited by 399
Self-citationWhole-Body Hypothermia for Neonates With Hypoxic???Ischemic Encephalopathy
Shankaran, S., Laptook, A. R., Ehrenkranz, R. A., Tyson, J. E., McDonald, S. A., Donovan, E. F., Fanaroff, A. A., Poole, W. K., Wright, L. L., Higgins, R. D., et al. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000201910.42613.6c · Cited by 357
Neuroprotection With Prolonged Head Cooling Started Before Postischemic Seizures in Fetal Sheep
Gunn, A. J., Gunn, T. R., Gunning, M. I., Williams, C. E., & Gluckman, P. D. (1998) · Pediatrics · doi:10.1542/peds.102.5.1098 · Cited by 324
Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans
Stohlawetz, P. J., Dzirlo, L., Hergovich, N., Lackner, E., Mensik, C., Eichler, H. G., Kabrna, E., Geissler, K., & Jilma, B. (2000) · Blood · doi:10.1182/blood.v95.9.2983.009k27_2983_2989 · Cited by 293
Maier, R. F., Obladen, M., Scigalla, P., Linderkamp, O., Duc, G., Hieronimi, G., Halliday, H. L., Versmold, H. T., Moriette, G., Jorch, G., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301701 · Cited by 269
Irradiation attenuates neurogenesis and exacerbates ischemia‐induced deficits
Raber, J., Fan, Y., Matsumori, Y., Liu, Z., Weinstein, P. R., Fike, J. R., & Liu, J. (2004) · Annals of Neurology · doi:10.1002/ana.10853 · Cited by 216
Zhu, C., Wang, X., Huang, Z., Qiu, L., Xu, F., Vahsen, N., Nilsson, M., Eriksson, P. S., Hagberg, H., Culmsee, C., et al. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402053 · Cited by 212
Self-citationErythropoietin: a candidate compound for neuroprotection in schizophrenia
Ehrenreich, H., Degner, D., Meller, J., Brines, M., Béhé, M., Hasselblatt, M., Woldt, H., Falkai, P., Knerlich, F., Jacob, S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001442 · Cited by 208
Voluntary running rescues adult hippocampal neurogenesis after irradiation of the young mouse brain
Naylor, A. S., Bull, C., Nilsson, M. K. L., Zhu, C., Björk-Eriksson, T., Eriksson, P. S., Blomgren, K., & Kuhn, H. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711128105 · Cited by 204
Self-citationErythropoietin Enhances Long-Term Neuroprotection and Neurogenesis in Neonatal Stroke
Gonzalez, F. F., McQuillen, P., Mu, D., Chang, Y., Wendland, M., Vexler, Z., & Ferriero, D. M. (2007) · Developmental Neuroscience · doi:10.1159/000105473 · Cited by 189
Erythropoietin Improves Functional and Histological Outcome in Neonatal Stroke
Chang, Y. S., Mu, D., Wendland, M., Sheldon, R. A., Vexler, Z. S., McQuillen, P. S., & Ferriero, D. M. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000163616.89767.69 · Cited by 175
Villa, P., van Beek, J., Larsen, A. K., Gerwien, J. G., Christensen, S., Cerami, A., Brines, M. L., Leist, M., Ghezzi, P., & Torup, L. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600370 · Cited by 160
Kellert, B. A., McPherson, R. J., & Juul, S. E. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3180332cec · Cited by 158
Mechanisms of Hypoxic Neurodegeneration in the Developing Brain
Johnston, M. V., Nakajima, W., & Hagberg, H. (2002) · The Neuroscientist · doi:10.1177/1073858402008003007 · Cited by 148
Erythropoietin Concentrations and Neurodevelopmental Outcome in Preterm Infants
Bierer, R., Peceny, M. C., Hartenberger, C., & Ohls, R. K. (2006) · PEDIATRICS · doi:10.1542/peds.2005-3186 · Cited by 146
Apoptosis in the Brains of Infants Suffering Intrauterine Cerebral Injury
Edwards, A. D., Yue, X., Cox, P. M., Hope, P. L., Azzopardi, D., Squier, M. V., & Mehmet, H. (1997) · Pediatric Research · doi:10.1203/00006450-199711000-00022 · Cited by 138
Juul, S. E., McPherson, R. J., Farrell, F. X., Jolliffe, L. K., Ness, D. J., & Gleason, C. A. (2003) · Neonatology · doi:10.1159/000074970 · Cited by 137
Ohls, R. K., Ehrenkranz, R. A., Das, A., Dusick, A. M., Yolton, K. A., Romano, E., Delaney‐Black, V., Papile, L. A., Simon, N. P., Steichen, J. J., et al. (2004) · PEDIATRICS · doi:10.1542/peds.2003-1129-l · Cited by 125
Erythropoietin in the Cerebrospinal Fluid of Neonates Who Sustained CNS Injury
Juul, S. E., Stallings, S. A., & Christensen, R. D. (1999) · Pediatric Research · doi:10.1203/00006450-199911000-00009 · Cited by 120
Wang, X., Zhu, C., Wang, X., Gerwien, J. G., Schrattenholz, A. S., Sandberg, M., Leist, M., & Blomgren, K. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02769.x · Cited by 118
Self-citationXenocostas, A., Cheung, W. K., Farrell, F. X., Zakszewski, C., Kelley, M. M., Lutynski, A., Crump, M., Lipton, J. H., Kiss, T. L., Lau, C. Y., et al. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0896-7 · Cited by 114
Casals‐Pascual, C., Idro, R., Gicheru, N., Gwer, S., Kitsao, B. S., Gitau, E., Mwakesi, R., Roberts, D. J., & Newton, C. R. J. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709715105 · Cited by 109
Wen, T. C., Rogido, M. R., Peng, H., Genetta, T., Moore, J. E., & Sola, A. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.057 · Cited by 75
Safety of High-Dose Recombinant Erythropoietin in a Neonatal Rat Model
McPherson, R. J., Demers, E. J., & Juul, S. E. (2006) · Neonatology · doi:10.1159/000096969 · Cited by 63
Cited by
Hypoxic-Ischemic Encephalopathy: A Review for the Clinician
Douglas-Escobar, M., & Weiss, M. D. (2015) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2014.3269 · Cited by 778
Lee, A. C., Kozuki, N., Blencowe, H., Vos, T., Bahalim, A., Darmstadt, G. L., Niermeyer, S., Ellis, M., Robertson, N. J., Cousens, S., et al. (2013) · Pediatric Research · doi:10.1038/pr.2013.206 · Cited by 665
Tertiary mechanisms of brain damage: a new hope for treatment of cerebral palsy?
Fleiss, B., & Gressens, P. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70058-3 · Cited by 365
Neonatal Hypoxia Ischaemia: Mechanisms, Models, and Therapeutic Challenges
Millar, L. J., Shi, L., Hoerder-Suabedissen, A., & Molnár, Z. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00078 · Cited by 348
A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
Juul, S. E., Comstock, B. A., Wadhawan, R., Mayock, D. E., Courtney, S. E., Robinson, T., Ahmad, K. A., Bendel-Stenzel, E., Baserga, M., LaGamma, E. F., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1907423 · Cited by 325
Metadata
- Authors
- Zhu, C., Kang, W., Xu, F., Cheng, X., Zhang, Z., Jia, L., Ji, L., Guo, X., Xiong, H., Simbruner, G., Blomgren, K., & Wang, X.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2009-08-01
- Volume
- 124
- Issue
- 2
- Pages
- e218-e226
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2153446990
- Cited by
- 354
- References
- 37
- FWCI
- 26.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.